Admission ECG abnormalities including QTc prolongation, atrioventricular block, QRS ≥120 ms, ST-segment and T-wave changes independently predicted MACE in ICI-associated myocarditis, with ECG burden score improving risk model C-index from 0.726 to 0.941.
Observational (n=60)
No
Do admission ECG abnormalities and a cumulative ECG burden score predict major adverse cardiovascular events in patients with immune checkpoint inhibitor-associated myocarditis?
Admission ECG abnormalities and a cumulative ECG burden score are powerful, independent predictors of MACE in ICI-associated myocarditis, providing incremental prognostic value over clinical and biomarker features.
Effect estimate: HR not explicitly provided but ECG burden score improved model C-index from 0.726 to 0.941
p-value: p=<0.05 for multiple ECG abnormalities
Immune checkpoint inhibitor (ICI)–associated myocarditis carries a high risk of mortality, yet electrocardiographic (ECG) predictors of adverse outcomes remain unclear. The present study aimed to evaluate the predictive value of clinical and admission ECG parameters for major adverse cardiovascular events (MACE). We retrospectively analyzed 60 consecutive patients with ICI myocarditis. Patients were stratified according to the occurrence of major adverse cardiovascular events (MACE), defined as myocarditis-related cardiogenic shock, high-degree atrioventricular block requiring temporary or permanent pacing, or sustained ventricular tachycardia(VT)/ventricular fibrillation(VF). Admission ECGs were systematically adjudicated for conduction and repolarization abnormalities, and an ECG burden score (0–6) was derived. Univariable and multivariable Firth penalized Cox regression models were used to identify predictors of MACE. Model performance was evaluated using discrimination and reclassification metrics across nested models: M1 (clinical variables), M2 (M1 + biomarkers and echocardiography), and M3 (M2 + ECG burden score). Among the 60 patients with myocarditis, MACE occurred in 21 patients (35%) patients. Compared with the non-MACE group, QTc prolongation (p = 0.011), QRS ≥ 120 ms((p = 0.002), Atrioventricular block (p = 0.007), bundle branch block (p = 0.005), ST-segment abnormalities (p = 0.003), and T-wave changes (p = 0.004) at the time of admission were more common in the MACE group. In multivariable Firth penalized Cox analysis, severe myocarditis, QTc prolongation, Atrioventricular block, QRS ≥ 120 ms, ST-segment abnormalities, T-wave changes, and higher ECG burden score independently predicted MACE. Sensitivity analyses excluding early MACE or in-hospital deaths confirmed robustness of results. Addition of ECG variables significantly improved model performance (C-index 0.726 M1 vs. 0.860 M2 vs. 0.941 M3), with significant net reclassification and integrated discrimination gains. Admission ECG abnormalities are powerful, independent predictors of adverse outcomes in ICI myocarditis and provide substantial incremental prognostic value beyond clinical and biomarker/echocardiographic features. Systematic ECG assessment and integration into risk stratification should be prioritized for early triage and monitoring in this high-risk population.
Zhou et al. (Fri,) conducted a observational in Patients with immune checkpoint inhibitor-associated myocarditis hospitalized at Peking Union Medical College Hospital (n=60). Admission electrocardiographic assessment including conduction and repolarization abnormalities with ECG burden scoring vs. No ECG abnormalities or low ECG burden score was evaluated on In-hospital occurrence of major adverse cardiovascular events (MACE) defined as myocarditis-related cardiogenic shock, high-degree atrioventricular block requiring pacing, or sustained ventricular tachycardia/fibrillation (HR not explicitly provided but ECG burden score improved model C-index from 0.726 to 0.941, p=<0.05 for multiple ECG abnormalities). Admission ECG abnormalities including QTc prolongation, atrioventricular block, QRS ≥120 ms, ST-segment and T-wave changes independently predicted MACE in ICI-associated myocarditis, with ECG burden score improving risk model C-index from 0.726 to 0.941.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: